CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience

Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach

Radiation Oncology Journal. 2022;40(3):192-199. Published online 2022 September 27 DOI: https://doi.org/10.3857/roj.2022.00101

Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience

Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach

Radiation Oncology Journal. 2022;40(3):192-199

Link1

Link2 Link3

SABR improves outcomes in men with recurrent oligometastatic prostate cancer

Tim Thomas

Nature Reviews Urology. 2020;17(5):256-256

Link1

Link2 Link3

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial

Steven David, Jennifer Tan, Peter Savas, Mathias Bressel, Dianne Kelly, Farshad Foroudi, Sherene Loi, Shankar Siva

The Breast. 2020;49:55-62

Link1 Link2

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer

Carole Mercier, Marc Claessens, Bart De Troyer, Tibaut Debacker, Karen Fransis, Hendrik Vandeursen, Piet Ost, Piet Dirix

Frontiers in Oncology. 2022;12:

Link1

EP-1550: Radiotherapy of PSMA-positive oligometastatic recurrent prostate cancer: a single-center experience

S.G.C. Kroeze, I.A. Burger, H. Garcia-Schüler, T. Hermanns, M. Guckenberger

Radiotherapy and Oncology. 2018;127:S836

Link1 Link2

What are the disease outcomes for patients with oligometastatic prostate cancer treated with Stereotactic Ablative Radiotherapy (SABR)?

A. Bald, A. Henry, F. Slevin, L. Murray, P. Dickinson

European Urology Open Science. 2022;45:S31

Link1 Link2

Preliminary results of Stereotactic Radiotherapy (SBRT) for Oligometastatic prostate cancer: Single institute experience

T. Basu, M.S. Senapati

European Urology Open Science. 2022;39:S56

Link1 Link2

Oligometastatic Prostate Cancer: Is it Only a Matter of Perspective?

Giuseppe Di Lorenzo, Carlo Buonerba

European Urology. 2019;75(5):705-706

Link1 Link2

Stereotactic ablative radiotherapy (SABR) for lung oligometastases can prevent or delay need for systemic anti-cancer treatment (SACT): single institution experience

Sophie Lynch, Shahreen Ahmad, Benjamin Taylor, Michael Skwarski, Daniel Smith

Lung Cancer. 2023;178:S56-S57

Link1 Link2

P3.08-01 Treatment Outcomes in Oligometastatic Disease of Non Small Cell Lung Cancer: A Single Center Experience

P. Akın Kabalak, D. Kızılgöz, Ü. Yılmaz, T. Inal Cengiz, E. Tunç, Ş. Yaman, E. Gülhan

Journal of Thoracic Oncology. 2018;13(10):S938-S939

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.